GLP-1 drugs have moved fast. They started as treatments for type-2 diabetes. Now they are a global health and consumer trend. In South Africa, medicines such as Ozempic and other semaglutide-based therapies are attracting wider attention. The reason is simple. These drugs reduce appetite and support weight management. They also sit within a bigger shift towards preventive health. Some researchers…